Meeting Date and Time
-
-
Location
Virtual via WebEx
Speaker(s)
Various
Sponsor(s)
NCI Division of Cancer Prevention
Date Posted
Agenda
Day #1: Wednesday, December 15 “Charting the Course!”
Moderator: Fred Hochberg, M.D., Consultant, Mass General Hospital | |
11:00 a.m. – 11:05 a.m. | Welcome Lynn Sorbara, Ph.D. Program Director, Cancer Biomarkers Research Group (CBRG) NCI/DCP |
11:05 a.m. – 11:20 a.m. | Introduction and Charge Sudhir Srivastava, M.P.H., Ph.D. Chief of CBRG, NCI/DCP |
Moderator: Richard Cote, M.D., Washington University | |
11:20 a.m. – 11:50 a.m. | "ctDNA: From Past Success to Clinical Integration"
Professor of Oncology, Director of Head and Neck Cancer, Johns Hopkins Medicine |
11:50 a.m. – 11:55 a.m. | Q/A |
11:55a.m. – 12:25 p.m. | “The Arena of Liquid Biopsy” Mark Watson, M.D., Ph.D. Associate Professor of Pathology and Immunology, Washington University School of Medicine |
12:25 p.m. – 12:30 p.m. | Q/A |
12:30 p.m. – 1:00 p.m. | “Personalized Medicine Initiatives and The Role of Novel Analytics” Razelle Kurzrock, M.D. Chief Medical Advisor and Co-founder, CureMatch |
1:00 p.m. – 1:05 p.m. | Q/A |
1:05 p.m. – 1:15 p.m. | Break |
Moderator: Nickolas Papadopoulos, Ph.D., Johns Hopkins University | |
1:15 p.m. – 1:45 p.m. | “Clinical Applications of Multi-analyte Analyses for Liquid Biopsy” Luis Diaz, M.D. Chief of Solid Tumor Oncology, Memorial Sloan Kettering |
1:45 p.m. – 1:50 p.m. | Q/A |
1:50 p.m. – 2:20 p.m. | “Circulating Tumor Cells: A Critical Analyte for Cancer Research and Management” Richard Schlegel, M.D., Ph.D. Chair of Pathology, Georgetown University |
2:20 p.m. – 2:25 p.m. | Q/A |
2:25 p.m. – 2:55 p.m. | “Cancer Early Detection, Classification and Monitoring using Plasma Cell-Free Methylomes” Daniel De Carvalho, Ph.D. Associate Professor, University of Toronto |
2:55 p.m. – 3:00 p.m. | Q/A |
3:00 p.m. – 3:45 p.m. | NCI Liquid Biopsy Consortium Forum Moderators: David Wong, D.M.D. University of California, Los Angeles Bob Carter, M.D. Massachusetts General Hospital Participation by all Consortium Members |
Day #2: Thursday, December 16 “Looking Ahead!”
11:00 a.m. – 11:10 a.m. | Recap of Day #1 and Path Forward Sudhir Srivastava, M.P.H., Ph.D. Chief of CBRG, NCI/DCP Lynn Sorbara, Ph.D. Program Director, CBRG, NCI/DCP |
11:10 a.m. – 11:30 a.m. | “NCI Vision for Liquid Biopsy” Philip Castle, Ph.D., M.P.H. Director, Division of Cancer Prevention, NCI |
11:30 a.m. – 11:35 a.m. | Q/A |
Moderator: Hakho Lee, Ph.D., Massachusetts General Hospital | |
11:35 a.m. – 12:05 p.m. | "Multi-Modal Data Integration for Fluid Biomarkers in Cancer"
Professor of Human Genetics, University of California, Los Angeles |
12:05 p.m. – 12:10 | Q/A |
12:10 p.m. – 12:40 p.m. | Title: TBA Sean Khozin, M.D., M.P.H. Chief Executive Officer of CancerLinQ LLC |
12:40 p.m. – 12:45 p.m. | Q/A |
12:45 p.m. – 1:15 p.m. | Title: TBA Puneet Souda, M.B.A. Managing Director, Life Science Tools and Diagnostics, SVB Leerink |
1:15 p.m. – 1:20 p.m. | Q/A |
1:20 p.m. - 1:30 p.m. | Break |
Moderator: Abhijit Patel, M.D., Yale University | |
1:30 p.m. – 2:00 p.m. | “Risk Benefit Analyses for Liquid Biopsy Studies” John Schneider, Ph.D. Chief Executive Officer and Founder of Avalon |
2:00 p.m. – 2:05 p.m. | Q/A |
2:05 p.m. – 2:35 p.m. | “Novel Approaches to Circulating Tumor Cell Analyses” Daniel Adams, B.S. Head Research Scientist, Director of Clinical R & D, Creatv MicroTech, Inc. |
2:35 p.m. – 2:40 p.m. | Q/A |
2:40 p.m. – 3:10 p.m. | “Finding the Needle in the Haystack!”
Stealth Biotech Company |
3:10 p.m. – 3:15 p.m. | Q/A |
3:15 p.m. – 3:45 p.m. | Wrap Up |
Points of Contact
Lynn Sorbara, Ph.D.
Email: lynns@mail.nih.gov
Juan Villanueva
Email: villanuevaju@mail.nih.gov